関連する実験動画
Updated: Jul 13, 2026
05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
269
胆管がんにおけるネオアジュバント治療は,切除性と生存率を改善する:前向きな研究
Anupam Lahiri1, Suchita Chowdhury2, Shaifali Goel1
1Department of GI and HPB Services, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, New Delhi, 110085, India.
まとめ
ネオアジュバント化学療法 (NACT) は,胆管がんの切除率を大幅に改善し,治療を完了した患者の60%以上で治癒的手術の機会を提供します. このアプローチは,局所的に進行した病気の生存に有望な利点を示しています.
科学分野:
- 腫瘍学 腫瘍学
- 外科腫瘍学外科腫瘍学
- 化学療法 化学療法とは
背景:
- 胆管がんは,診断時に切除能力が限られていると,予後が悪い.
- 胆管がんに対する新補助化学療法 (NACT) の有効性は十分に確立されていません.
研究 の 目的:
- 胆管がん患者の切除性と生存結果に対するNACTの影響を評価する.
- 将来の臨床環境におけるNACTの安全性と実現可能性を評価する.
主な方法:
- gallbladder carcinomaを患った226人の患者を対象とした前向きな単一センター研究です.
- 患者はゲムシタビン・プラチナベースのNACTを受け,その後応答評価を行った.
- 主要エンドポイントには,切除能力と全生存率の達成が含まれていました.
主要な成果:
- 治療する意図の切除率は36.2%で,NACT.を完了した患者では60.7%に増加しました.
- R0切除は切除された患者の95.1%で達成されました.
- 全体生存期間の中央値は,切除可能な症例で27カ月,切除できない症例で13カ月でした (p <0.001).
- グレード ≥3の毒性は,患者の9.7%で発生し,治療関連死亡率は1.7%でした.
結論:
- NACTは,治療を完了した胆管がん患者の治癒的切除率を大幅に高めています.
- この発見は,局所的に進行した胆囊がんの治療戦略にNACTを統合することを支持しています.
- NACTは,許容可能な毒性プロファイルと改善された生存結果を示しています.
関連する概念動画
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: